Intact IGF-I and IGF-II Mass Spectrometry for Accurate Quantitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for quantitatively analyzing insulin-like growth factors IGF-I and IGF-II using mass spectrometry are inefficient due to low digestion yields and non-specific enzyme cleavage, particularly with 'bottom-up' approaches, making accurate quantitation challenging.
Innovation Solution
A high-resolution/high-accuracy mass spectrometric method that analyzes intact IGF-I and IGF-II proteins without fragmentation, using techniques like electrospray ionization and high-resolution mass spectrometers such as orbitrap or time-of-flight, with optional purification steps like SPE and HPLC, to detect specific ion ranges corresponding to these proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If bottom-up approach with enzymatic digestion is used to analyze IGF-I and IGF-II, then quantitation can be performed, but digestion yield is low and non-specific enzyme cleavage occurs
Solution Approach 1:
The patent inverts the conventional bottom-up approach by using top-down intact protein analysis. Instead of digesting the protein into peptides for quantitation, the method directly analyzes the intact IGF-I and IGF-II proteins using mass spectrometry, thereby avoiding the low digestion yield and non-specific cleavage issues entirely while maintaining accurate quantitation capability
Solution Approach 2:
The patent extracts and analyzes only the intact protein molecules directly, separating them from the digestion process. By taking out the intact protein from the enzymatic digestion pathway and analyzing it separately through mass spectrometry, the method eliminates the harmful effects of incomplete digestion and non-specific cleavage while preserving accurate measurement
2Measurement precision
If intact protein analysis by high-resolution mass spectrometry is used, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent employs high-resolution mass spectrometry instruments (such as Orbitrap or TOF-SIMS) that can perform multiple functions: intact protein analysis, mass measurement, and quantitation all within a single system. This multi-functionality reduces the need for separate specialized equipment for each analysis type, thereby managing device complexity while achieving high measurement precision
3Reliability
If multiple chromatography steps (SPE and HPLC) are performed for purification, then measurement reliability is improved, but analysis time increases
Solution Approach 1:
The patent applies partial purification using solid phase extraction (SPE) followed by high performance liquid chromatography (HPLC), rather than complete purification. This partial action approach removes the most interfering substances to achieve sufficient measurement reliability while avoiding the time-consuming complete purification process, thus balancing reliability improvement with time loss reduction
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise quantitation of IGF-I and IGF-II with high accuracy and resolution, allowing for simultaneous determination of both proteins in a sample, improving the reliability and efficiency of their measurement in clinical and research applications.
Implementation Method 1
using techniques like electrospray ionization and high-resolution mass spectrometers such as orbitrap or time-of-flight
Implementation Method 2
high-resolution mass spectrometric method that analyzes intact IGF-I and IGF-II proteins without fragmentation, using techniques like electrospray ionization and high-resolution mass spectrometers such as orbitrap or time-of-flight
Data Source
AI summary
Methods are provided for determining the amount of an IGF-I protein in a sample using high resolution/high accuracy mass spectrometry. The methods generally include enriching the IGF-I protein in a sample, ionizing the IGF-I protein to generate one or more IGF-I ions, and determining the amount of the IGF-I ions with high resolution/high accuracy mass spectrometry.